PRECIGEN, INC. Proceeds from Lines of Credit
PRECIGEN, INC. (PGEN) reported Proceeds from Lines of Credit of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2023-03-06
- PRECIGEN, INC. proceeds from lines of credit for the quarter ending 2021-12-31 was $0.00.
- PRECIGEN, INC. proceeds from lines of credit for the quarter ending 2021-09-30 was $0.00.
- PRECIGEN, INC. proceeds from lines of credit for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. proceeds from lines of credit for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. proceeds from lines of credit for fiscal 2022 was $0.00.
- PRECIGEN, INC. proceeds from lines of credit for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- PRECIGEN, INC. proceeds from lines of credit for fiscal 2020 was $10.01M, a 14.90% decline from fiscal 2019.
- PRECIGEN, INC. proceeds from lines of credit for fiscal 2019 was $11.76M, a 157.77% increase from fiscal 2018.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-06 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $0.00 derived: sum of 3 quarters · filed 2023-03-06 | $0.00 10-K · filed 2023-03-06 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-06 | $0.00 derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $0.00 derived: sum of 3 quarters · filed 2023-03-06 | $1.29M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $1.29M derived: sum of 3 quarters · filed 2023-03-06 | $10.01M 10-K · filed 2023-03-06 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.29M derived: sum of 2 quarters · filed 2021-11-08 | $10.01M 10-Q · filed 2021-11-08 | $17.14M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $10.01M 10-Q · filed 2021-08-09 | $17.14M derived: sum of 3 quarters · filed 2022-03-01 | $18.51M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $8.72M 10-Q · filed 2021-05-10 | $15.85M derived: sum of 2 quarters · filed 2022-03-01 | $17.23M derived: sum of 3 quarters · filed 2022-03-01 | $19.07M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $7.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.51M derived: sum of 2 quarters · filed 2022-03-01 | $10.35M derived: sum of 3 quarters · filed 2022-03-01 | $11.76M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.21M derived: sum of 2 quarters · filed 2020-11-09 | $4.62M 10-Q · filed 2020-11-09 | $5.95M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $3.25M 10-Q · filed 2020-08-10 | $4.58M derived: sum of 3 quarters · filed 2021-03-01 | $5.53M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.41M 10-Q · filed 2020-05-11 | $2.74M derived: sum of 2 quarters · filed 2021-03-01 | $3.69M derived: sum of 3 quarters · filed 2021-03-01 | $4.73M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.28M derived: sum of 2 quarters · filed 2021-03-01 | $3.32M derived: sum of 3 quarters · filed 2021-03-01 | $4.56M 10-K · filed 2021-03-01 |
| 2018-09-30 | $953.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.99M derived: sum of 2 quarters · filed 2019-11-12 | $3.23M 10-Q · filed 2019-11-12 | $4.57M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.28M 10-Q · filed 2019-08-09 | $3.62M derived: sum of 3 quarters · filed 2020-03-02 | $4.86M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $1.24M 10-Q · filed 2019-05-09 | $2.58M derived: sum of 2 quarters · filed 2020-03-02 | $3.82M derived: sum of 3 quarters · filed 2020-03-02 | $5.47M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.58M derived: sum of 2 quarters · filed 2020-03-02 | $4.23M derived: sum of 3 quarters · filed 2020-03-02 | $5.91M 10-K · filed 2020-03-02 |
| 2017-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $2.88M derived: sum of 2 quarters · filed 2018-11-08 | $4.56M 10-Q · filed 2018-11-08 | $7.33M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $1.65M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | $3.32M 10-Q · filed 2018-08-13 | $6.09M derived: sum of 3 quarters · filed 2019-03-01 | $6.86M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $1.68M 10-Q/A · filed 2018-08-13 | $4.45M derived: sum of 2 quarters · filed 2019-03-01 | $5.21M derived: sum of 3 quarters · filed 2019-03-01 | $5.94M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $3.54M derived: sum of 2 quarters · filed 2019-03-01 | $4.26M derived: sum of 3 quarters · filed 2019-03-01 | $5.08M 10-K · filed 2019-03-01 |
| 2016-09-30 | $768.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.50M derived: sum of 2 quarters · filed 2017-11-09 | $2.31M 10-Q · filed 2017-11-09 | $3.82M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $728.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.54M 10-Q · filed 2017-08-09 | $3.05M derived: sum of 3 quarters · filed 2018-03-01 | $5.09M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $812.00K 10-Q · filed 2017-05-10 | $2.33M derived: sum of 2 quarters · filed 2018-03-01 | $4.36M derived: sum of 3 quarters · filed 2018-03-01 | $10.48M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.55M derived: sum of 2 quarters · filed 2018-03-01 | $9.67M derived: sum of 3 quarters · filed 2018-03-01 | $15.23M 10-K · filed 2018-03-01 |
| 2015-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $8.16M derived: sum of 2 quarters · filed 2016-11-09 | $13.72M 10-Q · filed 2016-11-09 | $17.72M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $6.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $11.68M 10-Q · filed 2016-08-09 | $15.68M derived: sum of 3 quarters · filed 2017-03-01 | $16.36M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $5.56M 10-Q · filed 2016-05-10 | $9.56M derived: sum of 2 quarters · filed 2017-03-01 | $10.23M derived: sum of 3 quarters · filed 2017-03-01 | $10.23M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.68M derived: sum of 2 quarters · filed 2017-03-01 | $4.68M derived: sum of 3 quarters · filed 2017-03-01 | $4.68M 10-K · filed 2017-03-01 |
| 2014-09-30 | $678.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $678.00K derived: sum of 2 quarters · filed 2015-11-09 | $678.00K 10-Q · filed 2015-11-09 | $678.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |